- Dosages
- Side effects in children
- Warnings & precautions in children
- Contra-indications in children
-
Interactions - PK
- Renal impairment
- References
Pharmacokinetics in children
Pharmacokinetic studies have not been performed
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
dose recommendation of formulary compared to licensed use (on-label versus off-label)
No information is present at this moment.
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
Available formulations
No information is present at this moment.
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
Dosages
| Active immunization against dengue |
|---|
|
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
Renal impaiment in children > 3 months
No information available on dose adjustment in renal impairment.
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
The complete list of all undesirable drug reactions can be found in the national Summary of Product Characteristics (SmPC) – click here
Side effects in children
Adverse reactions that were reported more frequently in children than in adults were fever (11% versus 3%), upper respiratory tract infection (11% versus 3%), nasopharyngitis (6% versus 0.6%), pharyngotonsillitis (2% versus 0.3%) and flu-like illness (1% versus 0.1%).
Adverse reactions reported less frequently in children than in adults were erythema at the injection site (2% versus 27%), nausea (0.03% versus 0.8%) and arthralgia (0.03% versus 1%)
In children < 6 years of age: Very often (>10%) decreased appetite, drowsiness, irritability.
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
The complete list of all contra-indications can be found in the national Summary of Product Characteristics (SmPC) – click here
Contra-indications
No information available on specific contra indications in children.
The complete list of all warnings and precautions can be found in the national Summary of Product Characteristics (SmPC) – click here
Warnings & precautions
No information available on specific warnings and precautions in children.
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
Interactions
The complete list of all interactions can be found in the national Summary of Product Characteristics (SmPC) – click here
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
| Encephalitis vaccines | ||
|---|---|---|
| J07BA02 | ||
| J07BA01 | ||
| Influenza vaccines | ||
|---|---|---|
| J07BB02 | ||
| Hepatitis vaccines | ||
|---|---|---|
| J07BC20 | ||
| J07BC02 | ||
| J07BC01 | ||
| Measles vaccines | ||
|---|---|---|
| J07BD52 | ||
| Poliomyelitis vaccines | ||
|---|---|---|
| J07BF03 | ||
| Rabies vaccines | ||
|---|---|---|
| J07BG01 | ||
| Rota virus diarrhea vaccines | ||
|---|---|---|
| J07BH01 | ||
| Varicella zoster vaccines | ||
|---|---|---|
| J07BK01 | ||
| Yellow fever vaccines | ||
|---|---|---|
| J07BL01 | ||
| Papillomavirus vaccines | ||
|---|---|---|
| J07BM03 | ||
| J07BM02 | ||
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
Reference
- Takeda GmbH, SmPC Qdenga (EU/1/22/1699/001) 30-1-2023, www.ema.europa.eu
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
Changes
Changes
